Global Electromyography Systems Market: introduction
Electromyography (EMG) is a diagnostic procedure. It is used for evaluation of health condition of muscles and nerve cells which are responsible for controlling the muscles.
These nerve cells are called motor neurons. Motor neurons are used for transmission of electrical signals that are responsible for causing muscles to contract and relax. An EMG translates these signals into numbers or graphs, aiding doctors to diagnose. A doctor generally orders an EMG when an individual is showing signs of a muscle or nerve disorder. These signs may include numbness, tingling, or unexplained weakness in the limbs. EMG results can help the doctor diagnose nerve disorders, muscle disorders, and disorders that affect the connection between nerves and muscles.
Read Report Overview:
Electromyography, or EMG, is study of an activity signal from the muscle itself, or from the top of a superficial muscle through electrodes attached on top of the skin. The information received can be used for showing relationships in research, or clinically for helping patients with biofeedback. Advanced EMG devices are witnessing surge in adoption for sports and fitness applications to study the biofeedback of nerve and muscle functioning. The small size of these devices and ease of use in flexible sports outfits is driving the demand for advanced EMG devices.
Global Electromyography Systems Market: Competition Landscape
Technological advancements such as advances in surface EMG detection and processing techniques, smart electrodes, on-board computing, auto-calibration, and high-bandwidth information decoding are propelling the adoption of EMG devices in various applications of medical studies and sports & fitness. Also, the key players are expanding their footprint in the emerging markets such as Asia pacific, to gain shares in the global electromyography systems market. For instance, in 2014, Natus Medical Incorporated announced the launch of the Vista Ultrasound System. The Vista Ultrasound System is the first product in the market to enable the use of Ultrasound with an EMG workstation. The Vista Ultrasound System added ultrasound capability to Natus' market-leading EDX and UltraPro S100 EMG workstations. In October 2014, Ambu, a leading global supplier of medical devices, has signed a distribution agreement with Intronix Technologies. Intronix Technologies' innovative Myoguide, an EMG guided injection system is available through Ambu's worldwide network of distributors, which already services Ambu's customers locally.
Request Brochure of the Report:
Global Electromyography Systems Market: Dynamics
Increase in Number of Neuromuscular Disorders
According to a study by NCBI, published in 2015, titled “The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature”, the incidence rates for ten disorders, range from 0.05 to 9 per 100,000 population per year. Most neuromuscular disorders showed prevalence rates ranging between 1 and 10 per 100,000 population. Compared to 1991, prevalence rates of Becker muscular dystrophy, myotonic dystrophy, facioscapulohumeral dystrophy, and Charcot-Marie-Tooth disease showed an increase, yet with highly overlapping ranges with the exception of myotonic dystrophy.